An oral, chemotherapy-free regimen (dasatinib plus prednisone) as induction and consolidation for adult patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia

被引：3
作者：
Li, Xue-Ying [1 ,2 ,3 ]
Qian, Jie-Jing [1 ,2 ,3 ]
Yang, Min [1 ,2 ,3 ]
Zhang, Yi [1 ,2 ,3 ]
Wang, Sha-Sha [1 ,2 ,3 ]
Meng, Hai-Tao [1 ,2 ,3 ]
Yu, Wen-Juan [1 ,2 ,3 ]
Tong, Hong-Yan [1 ,2 ,3 ]
Ye, Xiu-Jin [1 ,2 ,3 ]
Jin, Jie [1 ,2 ,3 ]
Zhu, Hong-Hu [1 ,2 ,3 ]
机构：
[1] Zhejiang Univ, Affiliated Hosp 1, Coll Med, Dept Hematol, Hangzhou, Zhejiang, Peoples R China
[2] Zhejiang Univ, Zhejiang Prov Key Lab Hematol Oncol Diag & Treatm, Hangzhou, Zhejiang, Peoples R China
[3] Zhejiang Univ, Inst Hematol, Hangzhou, Zhejiang, Peoples R China
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2020年 / 189卷 / 06期
基金：
中国国家自然科学基金;
关键词：
IMATINIB; PHASE-2;
D O I：
10.1111/bjh.16661
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E231 / E234
页数：4
相关论文
共 50 条
  • [11] More opportunities to advance paediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia
    Murphy, Lindsey
    Aldoss, Ibrahim
    LANCET HAEMATOLOGY, 2023, 10 (07): : E479 - E481
  • [12] Dasatinib and low-intensity chemotherapy for Philadelphia chromosome-positive acute lymphoblastic leukemia in a child with Down syndrome
    Hirabayashi, Shinsuke
    Hasegawa, Daisuke
    Yamamoto, Kaoru
    Nishimura, Akira
    Hosoya, Yosuke
    Shuo, Takuya
    Kiyokawa, Nobutaka
    Miura, Masatomo
    Takahashi, Naoto
    Manabe, Atsushi
    PEDIATRIC BLOOD & CANCER, 2019, 66 (05)
  • [13] Dasatinib-based 2-step induction for adults with Philadelphia chromosome-positive acute lymphoblastic leukemia
    Sugiura, Isamu
    Doki, Noriko
    Hata, Tomoko
    Cho, Ryuko
    Ito, Toshiro
    Suehiro, Youko
    Tanaka, Masatsugu
    Kako, Shinichi
    Matsuda, Mitsuhiro
    Yokoyama, Hisayuki
    Ishikawa, Yuichi
    Taniguchi, Yasuhiro
    Hagihara, Maki
    Ozawa, Yukiyasu
    Ueda, Yasunori
    Hirano, Daiki
    Sakura, Toru
    Tsuji, Masaaki
    Kamae, Tsuyoshi
    Fujita, Hiroyuki
    Hiramoto, Nobuhiro
    Onoda, Masahiro
    Fujisawa, Shin
    Hatta, Yoshihiro
    Dobashi, Nobuaki
    Nishiwaki, Satoshi
    Atsuta, Yoshiko
    Kobayashi, Yukio
    Hayakawa, Fumihiko
    Ohtake, Shigeki
    Naoe, Tomoki
    Miyazaki, Yasushi
    BLOOD ADVANCES, 2022, 6 (02) : 624 - 636
  • [14] SEVERE HEMORRHAGIC COLITIS CAUSED BY DASATINIB IN PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA
    Shimokaze, Tomoyuki
    Mitsui, Tetsuo
    Takeda, Hiroaki
    Kawakami, Takako
    Arai, Takahiko
    Ito, Masafumi
    Iwaba, Akiko
    Izumino, Hiroko
    Takahashi, Noriyuki
    Kanno, Miyako
    Sendo, Dai
    Hayasaka, Kiyoshi
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2009, 26 (06) : 448 - 453
  • [15] Dasatinib as an investigational drug for the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia in adults
    Brattas, Marte Karen
    Reikvam, Hakon
    Tvedt, Tor Henrik Anderson
    Bruserud, Oystein
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2019, 28 (05) : 411 - 420
  • [16] Dasatinib plus chemotherapy to achieve full donor chimerism and complete molecular remission in a child with relapsed philadelphia chromosome-positive acute lymphoblastic leukemia
    Tamamyan, Gevorg
    Chao, Yu-Hua
    Wang, Chung-Hsing
    Wu, Han-Ping
    Weng, Tefu
    Peng, Ching-Tien
    Wu, Kang-Hsi
    PEDIATRIC BLOOD & CANCER, 2013, 60 (10) : 1727 - 1728
  • [17] Ponatinib, chemotherapy, and transplant in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia
    Ribera, Josep-Maria
    Garcia-Calduch, Olga
    Ribera, Jordi
    Montesinos, Pau
    Cano-Ferri, Isabel
    Martinez, Pilar
    Esteve, Jordi
    Esteban, Daniel
    Garcia-Fortes, Maria
    Alonso, Natalia
    Gonzalez-Campos, Jose
    Bermudez, Arancha
    Torrent, Anna
    Genesca, Eulalia
    Mercadal, Santiago
    Martinez-Lopez, Joaquin
    Garcia-Sanz, Ramon
    BLOOD ADVANCES, 2022, 6 (18) : 5395 - 5402
  • [18] Treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia with imatinib in combination with chemotherapy
    Ohno R.
    Current Hematologic Malignancy Reports, 2006, 1 (3) : 180 - 187
  • [19] Current treatment strategies for Philadelphia chromosome-positive adult acute lymphoblastic leukemia
    Park, Han-Seung
    BLOOD RESEARCH, 2020, 55 : 32 - 36
  • [20] Long-term follow-up of a phase 2 study of chemotherapy plus dasatinib for the initial treatment of patients with Philadelphia chromosome-positive acute lymphoblastic leukemia
    Ravandi, Farhad
    O'Brien, Susan M.
    Cortes, Jorge E.
    Thomas, Deborah M.
    Garris, Rebecca
    Faderl, Stefan
    Burger, Jan A.
    Rytting, Michael E.
    Ferrajoli, Alessandra
    Wierda, William G.
    Verstovsek, Srdan
    Champlin, Richard
    Kebriaei, Partow
    McCue, Deborah A.
    Huang, Xuelin
    Jabbour, Elias
    Garcia-Manero, Guillermo
    Estrov, Zeev
    Kantarjian, Hagop M.
    CANCER, 2015, 121 (23) : 4158 - 4164
12345